Pilocytic Astrocytoma - 25 Studies Found
Active, not recruiting |
: Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma :
|
Recruiting |
: Phase II Pegylated Interferon :
: Drug: Pegylated interferon alpha-2b PEG-Intron 1mcg/kg/dose weekly through an injection under the skin o |
Recruiting |
: Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma :
|
Withdrawn |
: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors :
|
Recruiting |
: A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas :
|
Recruiting |
: Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors :
|
Recruiting |
: Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas :
|
Terminated |
: 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas :
|
Active, not recruiting |
: Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma :
|
Completed |
: RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma :
|